PE20090901A1 - Procedimiento para preparar derivados de 2-oxo-1,2,4,5-tetrahidro-1,3-benzodiazepina - Google Patents
Procedimiento para preparar derivados de 2-oxo-1,2,4,5-tetrahidro-1,3-benzodiazepinaInfo
- Publication number
- PE20090901A1 PE20090901A1 PE2008001362A PE2008001362A PE20090901A1 PE 20090901 A1 PE20090901 A1 PE 20090901A1 PE 2008001362 A PE2008001362 A PE 2008001362A PE 2008001362 A PE2008001362 A PE 2008001362A PE 20090901 A1 PE20090901 A1 PE 20090901A1
- Authority
- PE
- Peru
- Prior art keywords
- compound
- formula
- tetrahydro
- oxo
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102007038250A DE102007038250A1 (de) | 2007-08-13 | 2007-08-13 | Neues Herstellverfahren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20090901A1 true PE20090901A1 (es) | 2009-08-06 |
Family
ID=39877761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008001362A PE20090901A1 (es) | 2007-08-13 | 2008-08-11 | Procedimiento para preparar derivados de 2-oxo-1,2,4,5-tetrahidro-1,3-benzodiazepina |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8222402B2 (zh) |
| EP (1) | EP2195294A1 (zh) |
| JP (1) | JP2010535837A (zh) |
| KR (1) | KR20100053651A (zh) |
| CN (1) | CN101821237A (zh) |
| AR (1) | AR068806A1 (zh) |
| AU (1) | AU2008288429A1 (zh) |
| BR (1) | BRPI0815498A2 (zh) |
| CA (1) | CA2696205A1 (zh) |
| CL (1) | CL2008002376A1 (zh) |
| DE (1) | DE102007038250A1 (zh) |
| MX (1) | MX2010001600A (zh) |
| PE (1) | PE20090901A1 (zh) |
| TW (1) | TW200916461A (zh) |
| UY (1) | UY31283A1 (zh) |
| WO (1) | WO2009021942A1 (zh) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW221996B (zh) * | 1991-11-14 | 1994-04-01 | Glaxo Group Ltd | |
| US5883102A (en) * | 1995-10-17 | 1999-03-16 | Astra Pharmaceuticals Limited | Pharmaceutically active compounds |
| TR199801254T2 (xx) | 1995-12-29 | 1998-10-21 | Smithkline Beecham Corporation | Vitronektin resept�r� antagonistleri. |
| DE10250080A1 (de) * | 2002-10-25 | 2004-05-13 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| DE102004015723A1 (de) * | 2004-03-29 | 2005-10-20 | Boehringer Ingelheim Pharma | Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| DE102004018795A1 (de) | 2004-04-15 | 2005-10-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| EP1770091A1 (de) * | 2005-09-29 | 2007-04-04 | Boehringer Ingelheim Pharma GmbH & Co. KG | CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| DE102005038831A1 (de) * | 2005-08-17 | 2007-02-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| DE102007038251A1 (de) * | 2007-08-13 | 2009-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neues Herstellverfahren |
-
2007
- 2007-08-13 DE DE102007038250A patent/DE102007038250A1/de not_active Withdrawn
-
2008
- 2008-08-11 UY UY31283A patent/UY31283A1/es not_active Application Discontinuation
- 2008-08-11 PE PE2008001362A patent/PE20090901A1/es not_active Application Discontinuation
- 2008-08-12 WO PCT/EP2008/060559 patent/WO2009021942A1/de active Application Filing
- 2008-08-12 AU AU2008288429A patent/AU2008288429A1/en not_active Abandoned
- 2008-08-12 CL CL2008002376A patent/CL2008002376A1/es unknown
- 2008-08-12 MX MX2010001600A patent/MX2010001600A/es not_active Application Discontinuation
- 2008-08-12 CA CA2696205A patent/CA2696205A1/en not_active Abandoned
- 2008-08-12 BR BRPI0815498-8A2A patent/BRPI0815498A2/pt not_active Application Discontinuation
- 2008-08-12 KR KR1020107005404A patent/KR20100053651A/ko not_active Application Discontinuation
- 2008-08-12 US US12/672,093 patent/US8222402B2/en active Active
- 2008-08-12 TW TW097130726A patent/TW200916461A/zh unknown
- 2008-08-12 CN CN200880111399A patent/CN101821237A/zh active Pending
- 2008-08-12 AR ARP080103512A patent/AR068806A1/es unknown
- 2008-08-12 JP JP2010520553A patent/JP2010535837A/ja active Pending
- 2008-08-12 EP EP08803003A patent/EP2195294A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| UY31283A1 (es) | 2009-03-31 |
| EP2195294A1 (de) | 2010-06-16 |
| CA2696205A1 (en) | 2009-02-19 |
| WO2009021942A1 (de) | 2009-02-19 |
| JP2010535837A (ja) | 2010-11-25 |
| AR068806A1 (es) | 2009-12-09 |
| TW200916461A (en) | 2009-04-16 |
| AU2008288429A1 (en) | 2009-02-19 |
| DE102007038250A1 (de) | 2009-02-19 |
| CN101821237A (zh) | 2010-09-01 |
| MX2010001600A (es) | 2010-03-15 |
| US8222402B2 (en) | 2012-07-17 |
| CL2008002376A1 (es) | 2009-09-11 |
| BRPI0815498A2 (pt) | 2015-02-10 |
| US20110071286A1 (en) | 2011-03-24 |
| KR20100053651A (ko) | 2010-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2521596T3 (es) | Combinación del compuesto GlyT1 con antipsicóticos | |
| PE20090895A1 (es) | Derivados de triazol como inhibidores de la jak quinasa | |
| ES2571327T3 (es) | Composiciones plaguicidas | |
| CL2012001171A1 (es) | Procedimiento para la preparacion del ester n-[[2-[[[4-[[[(hexiloxicarbonil)]4-amino]iminometil]fenil]amino]metil]1-alquil-1h-benzimidazol-5-il]carbonil]n-2-piridinil-etilico de beta-alanina; y uno de los compuestos intermediarios considerados. | |
| PE20110854A1 (es) | DERIVADOS DE 1-FENIL-1H-PIRAZOLO[3,4-c]PIRIDINA-4-CARBONILAMINA COMO ANTAGONISTAS DE LOS RECEPTORES CCR1 | |
| AR068813A1 (es) | Derivados de pirazol sustituidos como antagonistas del receptor de androgenos (ar), un agente farmaceutico que los comprende y su uso en el tratamiento del cancer de prostata | |
| PE20120058A1 (es) | Derivados de imidazopirazina como inhibidores de syk | |
| AR071694A1 (es) | Procedimiento para la obtencion de arilcarboxamidas | |
| AR072166A1 (es) | Derivado de piperidina y su uso como inhibidor de renina superior | |
| UY32606A (es) | Sulfonamidas nematocidas | |
| UY28121A1 (es) | Activadores de glucoquinasa heteroaromaticos de seis miembros 5-sustituidos | |
| MX2009012885A (es) | Nuevo derivado de 1,2,3,4-tetrahidroquinoxalina que tiene, como sustituyente, grupo fenilo que tiene estructura de ester de acido sulfonico o estructura de amida de acido sulfonico introducida en este, y tiene actividad de enlace al receptor de gluco | |
| PE20091451A1 (es) | Derivados de imidazol como inhibidores de cinesina (ksp) | |
| WO2007149448A3 (en) | Pyrazinones as cellular proliferation inhibitors | |
| MX371337B (es) | Compuestos para protección de células. | |
| PE20081850A1 (es) | Derivados ciclizados como inhibidores de la eg-5 | |
| DOP2009000106A (es) | Compuestos de pirazol y triazol sustituídos como inhibidores de ksp | |
| NO20065231L (no) | Nye imidazoler | |
| AR082865A1 (es) | Derivados de triazolo[4,3-a]piridina, y sus usos | |
| AR071954A1 (es) | Derivados de 3-oxo-isoindol-1-carboxamida utiles en terapia para el dolor y una composicion farmaceutica que los comprende. | |
| PE20210862A1 (es) | Metodo para preparar 2-[(3r)-3-metilmorfolin-4-il]-4-(1-metil-1h-pirazol-5-il)-8-(1h-pirazol-5-il)-1,7-naftiridina | |
| AR083861A1 (es) | OXAZOLIDINONAS COMO MODULADORES DE mGluR5 Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN | |
| PE20090901A1 (es) | Procedimiento para preparar derivados de 2-oxo-1,2,4,5-tetrahidro-1,3-benzodiazepina | |
| JO3029B1 (ar) | مشتقات مبتكرة مضادة للفطريات ل 5 ، 6 - ثاني هيدرو - 4- [(ثاني فلورو اثيل) فينيل] -4 H - بيرولو [2،1 -a ] [1،4] بينزوديازيبين و 4- ( ثاني فلورو اثيل ) فينيل - 6 H - بيرولو [2،1 -a ] [1،4] بينزوديازيبين | |
| AR062477A1 (es) | Formulacion aerosol para la inhalacion de beta - agonistas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |